Dark Forest Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Dark Forest Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-46	Closed	-$1.06K	–	1480
2022 Q4	$1.06K	Sell	46 -83	-64%	-$1.91K	﹤0.01%	984
2022 Q3	$3K	Buy	+129	New	+$2.5K	﹤0.01%	986

Other funds holding TMCI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dark Forest Capital Management's TMCI Position: Q1 2023 in Review

Dark Forest Capital Management sold out of Treace Medical Concepts (TMCI) in Q1 2023, closing a stake of 46 shares — an estimated $1.06K sold.

Dark Forest Capital Management first reported a position in TMCI in Q3 2022 and held it in 2 quarters. The position peaked at $3K in Q3 2022. 123 funds tracked by Wall St. Rank hold TMCI as of Q1 2023.

Dark Forest Capital Management reported no remaining Treace Medical Concepts position as of Q1 2023 after selling out during the quarter.
Dark Forest Capital Management sold 46 Treace Medical Concepts shares in Q1 2023, an estimated $1.06K.
Dark Forest Capital Management first reported a position in Treace Medical Concepts in Q3 2022 and held it in 2 quarters.
Dark Forest Capital Management's Treace Medical Concepts position peaked at $3K in Q3 2022.
123 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2023.

Based on Dark Forest Capital Management's 13F filing for Q1 2023, filed 12 May 2023.